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Physical Therapy Intervention for
People With Huntington Disease
Monica E Busse, Hanan Khalil, Lori Quinn, Anne E Rosser
Background andPurpose. The clinical symptoms of Huntington disease (HD)
include progressive movement disorders, cognitive deficits, and behavioral changes,
all of which affect an individual’s ability to participate in activities of daily living. To
date, very few quantitative or qualitative studies have been conducted to guide
physical therapists working with people with HD. The objective of this study was to
characterize current physical therapist practice for people with HD, thus informing
the development of standardized clinical care and future research studies.
Subjects and Methods. Consultation with physical therapists working with
people with HD was undertaken in the form of mailed questionnaires (n49) and
semistructured interviews (n8). The development of the interview schedule was
aided by consideration of the data obtained from the questionnaires. Themes iden-
tified from the interviews were considered in light of published literature and
questionnaire responses.
Results. The main issues that emerged from the interviews were classified into 3
subthemes: (1) there is insufficient use of routine physical therapy–related outcome
measures at different stages of HD, (2) there is underutilization of physical therapy
services in managing HD (particularly in the early stages), and (3) the management of
falls and mobility deficit progression is a key treatment aim for people with HD.
Discussion and Conclusion. A conceptual framework for physical therapy
intervention in HD was developed on the basis of the themes that emerged from the
data in this study. Such a framework has utility for complex, progressive conditions
such as HD and may facilitate clinical decision making and standardization of practice
and affect the development of future physical therapy trials.
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Huntington disease (HD) is aninherited, neurodegenerativecondition resulting in clinical
symptoms of progressive movement
disorders, cognitive deficits, and be-
havioral changes that may affect an
individual’s ability to participate in
activities of daily living, work, and
community. The current manage-
ment of HD is focused on symptoms
because there is no curative treat-
ment.1 Physical therapy may play a
role in assisting people with HD to
maintain their independence in ac-
tivities of daily living by addressing
both impairments and limitations in
functional activities.
Despite the potential for physical
therapy to assist people with HD,
evidence suggests that people with
HD are not always routinely referred
for physical therapy, particularly in
the early stages.2–4 This lack of refer-
ral may be attributable to the limited
scientific support for the effective-
ness of physical therapy interven-
tions in HD.5 Although animal mod-
els and small-scale studies of physical
therapy in humans have led to the
belief that directed physical activity,
environmental enrichment, and
training may be beneficial, clinical
judgment, experience, and trial and
error remain the major mechanisms
through which interventions are
justified.2,6–11
A recent study12 investigated the
benefits of participation of patients
with early- and middle-stage HD in
an inpatient rehabilitation program.
The treatment program included
respiratory exercises and speech
therapy, physical therapy, and occu-
pational therapy. Patients were ad-
mitted for 3-week periods of inten-
sive treatment that were repeated 3
times per year for 2 years. Data from
the first year indicated that 25 of the
initial 40 patients who started the
study completed the 3 admissions
during that year; only 11 patients
completed all of the 6 admissions in
the 2 years. Each 3-week period of
treatment resulted in highly signifi-
cant (P.001) improvements in mo-
tor performance, as measured by the
Physical Performance Test (PPT). No
motor decline, as measured by the
PPT, was detected over 2 years
(n11). These findings give some in-
dication that intensive rehabilitation
positively influences motor and func-
tional performance in patients with
early- and middle-stage HD. The com-
ponents of the provided rehabilita-
tion that resulted in change could
not be clearly determined.
The design and implementation of
randomized controlled trials for peo-
ple with HD are limited by a lack of
knowledge of the specific content of
interventions. Obtaining knowledge
about the content of programs cur-
rently being implemented is an im-
portant step in providing therapists
with the information to develop more
standardized methods of intervention
and to initiate further research that
can determine the benefits of specific
physical therapy interventions in a
controlled manner.
The purpose of this study was to
identify the specific components of
physical therapy practice for people
with HD. Specific research questions
were: (1) What is the nature of phys-
ical therapist practice? and (2) What
are the influential limiting factors rel-
evant to the provision of physical
therapy for people with HD? Be-
cause this study was focused on de-
veloping an understanding of physi-
cal therapist practice relative to HD,
a qualitative methodology was con-
sidered appropriate. Qualitative re-
search most typically involves the de-
velopment of concepts that may
emerge into theory13 and, therefore,
was the approach of choice in this
study.
Method
Study Design and Approach
In order to describe the nature of
physical therapy practice, consulta-
tion in the form of semistructured
telephone interviews with physical
therapists based in specialized HD
centers was undertaken. A prelimi-
nary questionnaire study was also
conducted. This questionnaire data
contributed to the development of
the interview questions and further
facilitated triangulation during the
later stages of the study. From the
interviews, in-depth information was
gathered from participants relating
to their experiences in the assess-
ment and treatment of people with
HD. Ultimately, the data were used
to develop guidelines and a theoret-
ical framework for physical therapy
practice specifically relevant to peo-
ple with HD.
The semistructured telephone inter-
view, which was the primary
method of data collection in this
study, allowed exploration of the is-
sues of interest with the use of open-
ended questions without the con-
straint of predetermined categories
of analysis.14 In accordance with this
method, a “grounded theory” ap-
proach was used to influence data
gathering and analysis.15 This has
been described as an approach that
“starts from the ground and works
up in an inductive fashion to make
sense of what people say about their
experiences, and then to convert
those statements into theoretical
propositions.”15(p102)
Study Procedures
Preliminary questionnaires. Physi-
cal therapists with a special interest
in neurology (n200) were selected
randomly from the United Kingdom
Association of Chartered Physiother-
apists Interested in Neurology re-
search database to receive a mailed
questionnaire. Stamped, self-addressed
envelopes were provided for the
return of the completed question-
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naires. The questionnaire comprised
3 sections. The first section collected
respondents’ demographic details
relevant to their treatment of people
with HD. The second section con-
sidered referral for physical therapy
and the treatments provided. Open-
ended questions were used to obtain
qualitative information about issues
such as falls and the effects of be-
havior and dementia on physical
therapy treatments. The third sec-
tion included questions about guide-
lines for care and outcome measures
routinely used in the treatment of
people with HD.
Semistructured interviews. In or-
der for the interviews to yield suffi-
cient amounts of descriptive data, we
used a purposive sampling strategy14
that involved recruiting physical ther-
apists from a broad geographical area
and with a range of experiences to be
interviewed. Participants were special-
ist physical therapists who had expe-
rience working with people with HD.
Table 1 provides a detailed description
of the participants.
There are no established rules to aid
in sample size determination in qual-
itative research.16 The decision as to
when sufficient participants had been
interviewedwas related to the point at
which no new themes emerged; that
is, when theoretical saturation was
achieved.13 Eight participants were re-
cruited for this study, and the initial
analysis of transcribed data indicated
that the saturation point had been
achieved. Interviewing was discon-
tinued at this stage, and further anal-
ysis of the conducted interviews
confirmed that recurrent themes ap-
peared to be emerging in all of the
interviews.
The participants were recruited via
advertisement on the Chartered So-
ciety of Physiotherapy discussion
board. All of the telephone inter-
views were conducted by one re-
searcher and audio recorded. Field
notes were made by an additional
researcher, who also was present
during all of the interviews. Special
attention was given within the inter-
view process to reframing, repeti-
tion, and expansion of the questions
as required, thus enhancing the cred-
ibility of the information that was
obtained. The interviewer used a
preplanned schedule (Appendix) that
served as a checklist for the questions
covered during the course of each in-
terview and as a guide toward the
topic areas for discussion, thereby fa-
cilitating a consistent and systematic
method of data collection. The devel-
opment of the interview schedule was
aided by consideration of the data ob-
tained from the preliminary question-
naires. The schedule aimed to cover 3
basic topic areas during each inter-
view: (1) assessment and treatment
planning according to the stage of the
condition; (2) the effects of specific
issues, such as behavior and dementia
problems, on the management of HD;
and (3) departmental policies with re-
spect to people with HD and, specifi-
cally, with respect to the potential for
developing care guidelines.
Responses to open-ended questions
were analyzed with a thematic ap-
proach. Closed questions were
coded and then entered into and an-
alyzed descriptively with the Statisti-
cal Package for the Social Sciences
(version 14).*
Interview Data Analysis
The interviews were transcribed in
full into text. This process of full
transcription helped to strengthen
the trustworthiness of the data by
avoiding selective recording of the
information.14 Ensuring the truth
value of the study, the accuracy of
the transcripts was confirmed by
both the interviewer and the inde-
pendent researcher as well as by
consultation with the participants
* SPSS Inc, 233 S Wacker Dr, Chicago, IL
60606.
Table 1.
Participant Experience in Working With People With Huntington Disease (HD)
Participant Place of Current Work Specific Experience With HD
1 Neurological rehabilitation unit Average of 1 or 2 adults with HD per year over the last 10 y.
2 Specialized HD unit Many adults with HD and mainly psychiatric problems. Average of 15–20
people per year over the last 4 y in a private setting.
3 Specialized HD unit Average of 11–15 people per year over the last 18 y in an HD day therapy
unit and community outreach service.
4 General hospital One case of juvenile HD.
5 Specialized HD unit Average of 10 people per year over the last 5 y (adults and older people with
HD in an HD day therapy unit).
6 General hospital Average of 1 or 2 people per year over the last 18 y.
7 Mental health team One case of adult HD; referral for anxiety.
8 Community physical disability team Average of 15–20 people per year.
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who were interviewed.17 Copies of
the transcripts were sent, along with
self-addressed, stamped return enve-
lopes, to the interviewed partici-
pants, inviting them to comment on
whether the transcripts fully repre-
sented their ideas or not. Final
themes also were sent to the partic-
ipants for comment.
A qualitative data analysis package
(QSR Nvivo, version 2.0.163†) was
used to aid in the analysis process for
the interview data. All codes were
saved within the NVivo database as
nodes. As a result of highlighting ar-
eas that were unclear and perform-
ing further coding and refinement,
the initial nodes were reordered, du-
plicated, or merged. Following iden-
tification of the themes, labeling and
layering of connections between
ideas and concepts were performed
with the modeling option in NVivo.
Final themes were agreed on by
the research team and were sent to
the participants for checking. The
themes were further cross-checked
and triangulated with the prelimi-
nary questionnaire data as well as
with information obtained from a
critical review of available literature.
This process allowed us to confirm
the content and the results obtained
from the interviews.18
Results
Preliminary Questionnaires
Of 200 questionnaires sent, 118
(59%) were returned and included in
the analysis. Of the 118 respondents,
49 had treated an individual with HD
during the course of their career. All
of these 49 respondents had ob-
tained their training in the United
Kingdom. The respondents had an
average of 15.3 years of experience
(range2.5–40). Therapists ranged
in position from staff physical thera-
pist to senior therapist/clinical spe-
cialist. Therapists practiced in a
range of environments, including
hospitals, outpatient settings, and
specialized long-term-care HD units.
The majority of the therapists treated
1 or 2 patients per annum (46.2%
and 38.5% of total questionnaire re-
sponses, respectively). The thera-
pists most frequently saw patients in
the middle and late stages of the dis-
ease (47.3% of the respondents for
both). Only 5.3% of the respondents
saw patients in the early stage.
Table 2 shows a summary of the
questionnaire results related to refer-
ral for physical therapy and evalua-
tion procedures. Table 3 summarizes
the respondents’ answers about
types of interventions that they used
for people at different stages of HD.
In the early tomiddle stages, therapists
generally implemented a problem-
oriented approach and focused on
functional activity training; in the late
stages, therapists began focusing more
on respiratory therapy.
Semistructured Interviews
All 8 recruited participants had ob-
tained their undergraduate training
in the United Kingdom. All were se-
nior physical therapists with varied
work experience in the field of neu-
rological rehabilitation (Tab. 1).
† QSR International Pty Ltd, 225-R Concord
Ave, Cambridge, MA 02138.
Table 2.
Summary of Questionnaire Results Relating to Referrals and Evaluation Procedures
Question Response Valid Percentage of
Respondents Giving
That Response (N49)
Most common no. of people
treated per year?
0 5.1
1 46.2
2 38.5
5 10.2
First referral? Presymptomatic 0.0
Early stage 8.9
Middle stage 53.3
Late stage 37.8
Most frequent referral
reason?
Mobility, balance, falls 57.1
Deteriorating function 20.0
Assessment only 8.5
Advice and support 5.7
Moving and handling 2.9
Respiratory 2.9
Seating 2.6
Are falls an issue? Yes 95.3
Is behavior a limitation? Yes 58.5
Is motivation a limitation? Yes 56.4
Is dementia a limitation? Yes 74.3
Is a physical therapy
guideline available?
No 95.4
What outcome measures
should be used in treating
people with Huntington
disease?
None 44.4
Rating scales and timed tests 35.6
Rating scales only 11.1
Timed tests only 6.7
Goal setting 2.2
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The questions used for the semi-
structured interviews are shown in
the Appendix. The main issues that
emerged from the interviews were
classified into 3 subthemes: (1) there
is insufficient use of routine physical
therapy-related outcome measures at
different disease stages, (2) there is
underutilization of physical therapy
services in managing HD (particu-
larly in the early stages), and (3) the
management of falls and mobility
deficit progression is a key treatment
aim for people with HD. The identi-
fication of these 3 subthemes led to
the development of an overriding
master theme: The management of
HD must be modified according to
an individual’s problems and to the
stage of disease (Fig. 1).
Subtheme 1: Insufficient use of
physical therapy–related out-
come measures that address HD-
specific problems. Functional as-
sessments were considered the most
appropriate method of evaluation.
Participants reported using general
mobility assessments that were part
of the assessment procedures at their
hospital or facility. These included
observational items, such as move-
ment from a sitting position to a
standing position, sitting and stand-
ing balance, bed mobility, walking,
and use of stairs. The participants
were in agreement that functional
assessments yielded the most infor-
mation for them to make appropriate
clinical decisions. Participant 6 said:
I think that much more important re-
ally is to know what they can do. For
example, if they can get to the toilet,
get up or down stairs, make them-
selves a meal, etc, that is much more
important than them being able to
walk 10 m outside.
However, participants did express a
desire for more functionally relevant,
validated outcome measures. Al-
though several participants realized
the potential for standardized tests
for the purposes of obtaining infor-
mation about an individual’s current
functional status (eg, 10-m walk test)
and highlighting the nature of any
impairments (eg, Berg Balance Scale,
Timed “Up & Go” Test [TUG]), none
of the therapists was currently using
any tools as outcome measures to
assess the effectiveness of specific
physical therapy interventions. Par-
ticipants agreed that it would be fea-
sible to use the types of measures
that are used for people with other
neurological conditions. Data from
the questionnaires revealed that 57%
of the respondents who did report
using outcome measures routinely
used a combination of rating scales
and timed tests (such as the Berg
Balance Scale, the TUG, and the 10-m
walk test).
However, it was suggested that al-
though these measures might be
used as baseline measures, they
might not be good indicators for pre-
dicting the probability of the risk of
falls in people with HD. Participant 2
said:
I sometimes use the Berg Balance
Scale, but it is far from the ideal when
you’ve got patients who got 25, 26 on
Berg Balance Scale and are pretty
much largely independently mobile
with the occasional fall. Most people
with other conditions and such
scores would not be able to walk and
have recurrent falls. So, from that
point of view, it is not a good indica-
tor except as a baseline to see how
they are getting on.
None of the interviewed participants
reported access to scores on the Uni-
fied Huntington’s Disease Rating
Scale (UHDRS), even though the test
was designed specifically for HD and
includes a Motor Assessment and a
Functional Assessment. The UHDRS
is an observer-rated and clinic-based
outcome measure that may not re-
flect what people are actually able to
do in their own environments. Par-
ticipant 6 said:
Table 3.
Types of Interventions Most Frequently Used by Therapists for People at Different
Stages of Huntington Disease (HD)a
Intervention Valid Percentage of Respondents Using That Intervention for HD at
Following Stage (n49):
Presymptomatic Early Middle Late
No treatment 86.7 62.2 26.7 33.3
Balance, mobility,
and prevention
of falls
2.2 2.2
Core stability 2.2 2.2
Provision of
equipment and
postural
support
2.2
Physical
conditioning
2.3
Problem-oriented
approach and
functional
activities
6.7 33.3 55.5 15.6
Respiratory
therapy
2.2 4.5 13.3 44.4
Patient education 2.3
a No entry in a cell indicates no response to that particular intervention for that stage.
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It is so difficult, because there are so
many outcome measures out there. I
deal a lot with multiple sclerosis (MS),
and there is not one that suits every-
body, and I really get upset because
the clinic uses the EDSS [Expanded
Disability Status Scale], which is sim-
ilar to the UHDRS for HD; I found that
does not mean anything. I mean there
are a lot of variables. Time of day,
place of assessment, people are ner-
vous, and it does not necessarily re-
late to what the patient can do at
home.
In summary, there was agreement
that functional assessments provided
the most information for therapists
to make appropriate clinical deci-
sions and to guide their interven-
tions. Although therapists recognized
the need for using outcome measures,
they were unsure of which tools were
most appropriate to use.
Subtheme 2: Underutilization of
physical therapy services in man-
aging HD. A second subtheme
that emerged from the interviews
was that physical therapy services
were underutilized for people with
HD, particularly in the early stages.
The main issues discussed were pol-
icies for the referral of people with
HD for physical therapy services, the
number of people referred per year,
and the stages at which referral oc-
curred. The responses regarding the
number of people referred for phys-
ical therapy services differed accord-
ing to the areas in which the people
were referred. Interviewed partici-
pants working in nonspecialist areas
such as general hospitals (partici-
pants 4 and 6) treated 1 or 2 people
per year. In contrast, participants
working in specialist areas such as
specialized HD units (participants 2,
3, and 5) reported treating larger
numbers of people (10–20) per year.
Most of the interviewed participants
reported that referrals occurred in
the middle to late stages of the dis-
ease, although there was agreement
that physical therapy would be most
beneficial in the early stages.
Participant 1 was particularly con-
cerned about the lack of early inter-
vention and indicated that because
early-stage referral was achievable
for people with Parkinson disease, it
also should be available for those
with HD. This participant indicated
that the benefits of early-stage inter-
vention would include helping the
therapist to establish a baseline, es-
tablishing a relationship with the pa-
tient and the caregivers at an early
stage, and assisting the patient in
maintaining mobility and functional
independence for as long as possi-
ble. This participant said:
We do not see them early enough. We
do not see them as soon as diagnosed
in the same way as we see MS pa-
tients, very close to diagnosis. It used
to be a problem with Parkinson dis-
ease, we used to see them at the very
late stages, but we see them now
much, much earlier, so with HD, if we
see people earlier, then we can have
baselines and establish relationships
with people and their carers from that
early stage, and then give them advice
on activities to maintain mobility.
Other factors related to people with
HD themselves were considered to
influence the initial referral for phys-
ical therapy services. Participant 3,
working in a day therapy unit and a
community outreach service, com-
mented that people in the presymp-
tomatic stage rarely were seen in the
clinic and instead were seen in the
community setting. Participant 3 felt
strongly that fear of the future may
Figure 1.
Representation of the 3 subthemes and the master theme for Huntington disease (HD).
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act as a barrier to coming to a clinic,
where they may see what the future
would be like, saying:
A lot of patients that start as outreach
are perhaps the children of patients
who are actually coming into the unit.
They may be presymptomatic, and
they do not want to come to the unit,
where they may see what the future
holds.
Participant 6 added that a patient’s
refusal to confront or acknowledge
the problem might be another fac-
tor, saying:
I would say that I have not seen pre-
symptomatic. I’ve seen 2 or 3 patients
at the early diagnosis side of it, just
after they’ve being diagnosed. Most of
those who were diagnosed ignore it
unless the families were keen on our
involvement.
Thus, the problem of early-stage re-
ferral may be multifaceted. Although
most of the interviewed participants
received referrals in the middle to
late stages of the disease, the more
experienced therapists felt strongly
that they did not see people with
HD early enough. They agreed that
physical therapy would be most ben-
eficial in the early stages of the
condition.
Subtheme 3: Management of falls
and mobility deficit progression
in HD is a key treatment aim. All
participants identified falls and risk
of falls as some of the primary prob-
lems that need to be addressed in
people with HD. The progressive
nature of the disease results in al-
terations in mobility that place peo-
ple in a high-risk category for falls
and injuries. Accordingly, prevention
of falls was suggested as an impor-
tant element in a physical therapy
program implemented for people
with HD.
Facilitation of the development of
coping strategies was one of the
methods recommended for reducing
the risk of falls in people with HD.
Despite the fact that people with HD
in the late stages look unsafe and
uncontrolled when they move, many
of the participants believed that gait
should not be corrected or changed.
It may be preferable to allow people
to develop their own coping strate-
gies. Participant 1 said:
I have not felt that I could intervene
in such a way to make a significant
change in their gait, and I have been
afraid that by trying to do something,
that could actually interfere with the
way that these individuals have devel-
oped their gait. I have not tried to
modify the gait but to modify the en-
vironment and the carer.
The fact that safety and mobility may
become severely compromised in
the late stages of the disease was
commented on by participant 1,
who said:
I think for anybody observing some-
one at the late stage of HD with mul-
tiple choreic movements occurring
during the day, it is frightening to
watch, it just looks very dangerous
and very uncontrolled even though
the person can actually move from
point A to B safely; it does look very
unsafe and then we need to introduce
that to the home environment where
there are a lot more things to go
wrong, to trip over.
With regard to what is believed to be
safe performance of an activity (such
as ambulation), participants believed
that there were frequent disagree-
ments between family members or
caregivers and people with HD.
Therapists working with people
with HD should acknowledge and
accept the need of these people for
functional independence. It seems
that this is part of living with the
disease, although it may mean an in-
creased risk of injuries from falls. Par-
ticipant 3 said:
We had one patient, a very young
man . . . and had great difficulties
with him when he wanted to mobi-
lize. The unit staff were really very
concerned because he was falling so
much when he got out of his chair,
and they were rushing to prevent him
getting up, which he found frustrat-
ing. In the end, we agreed on a com-
promise, where he would be allowed
to mobilise freely and the staff would
not get too close . . . that was the way
he was less likely to fall.
On the basis of the data from the
interviews, walking aids for safer mo-
bility can be prescribed for people
with HD. However, their use should
be individually assessed and treated
with caution. It seemed that most
therapists believed that walking aids
such as walkers and canes were
more of a hindrance. Chorea can
mean that a walking aid becomes
more of a hazard for people with
HD. In addition, some people with
HD have difficulty with persistent
motor activity and are therefore
likely to let go of the aid while using
it. With regard to cognition-related
issues, some people may have diffi-
culties navigating the environment
with the aid, an issue that may in-
crease the risk of falls. These aspects
relating to the use of walking aids for
people with HD were commented
on by participants 1, 6, and 8. Partic-
ipant 1 said:
We will provide walking aids as they
need them. We tend to find that they
are resistant to using walking aids,
and sometimes it is difficult. I think
with choreic movement that would
cause them more trouble. They can
trip over them or harm themselves.
Participant 8 summarized:
Sometimes providing walking aids
seems to make them worse, espe-
cially if they get festinate in their gait,
it seems to hinder them. If they are
falling and use side steps or step to
save, then the aids get in the way. It is
more trial and error with walking aids
as to what they receive, when and
how effective they are.
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Participant 6 agreed with these 2
participants and said:
From an aids point of view, I think it
is very difficult, because I do not think
we have ever been successful supply-
ing anybody with a walking aid be-
cause of the arm movement. Some-
times if you can get them to
concentrate long enough, they can do
it, but of course towards the end, their
concentration is poor. I mean there are
so many cognitive problems as well.
Participants believed that teaching
people to develop compensatory
strategies would be most effective in
aiding in the prevention of falls.
These strategies included developing
coping mechanisms, modifying the
environment, modifying caregiver
behavior, and providing aids in cer-
tain situations.
Master theme. The 3 subthemes
all related to a master theme that
emerged from our analysis: Physical
therapy management of HD must be
modified according to an individual’s
problems and to the stage of the dis-
ease. To illustrate this master theme,
we extended a framework (Fig. 2)
originally developed by Dal Bello-
Haas19 for people with neurodegen-
erative diseases. When the interview
responses from main questions 1 and
3 (Appendix) are applied, this frame-
work relates specifically to people
with HD and is supported by state-
ments made by the participants.
The respondents identified func-
tional deterioration as being corre-
lated with increases in the number
and severity of motor impairments,
as indicated by participant 8, who
said:
At the early stage . . . more balance
and flexibility problems, coordina-
tion, and sometimes loss of muscle
strength. Mild to moderate [mid-
stage] usually includes problems with
walking and falls and sometimes pos-
ture problems and provision of equip-
ment. Severe [late stage] tends to be
more maintaining range of move-
ment, posture, and flexibility.
Therapists reported that at different
stages of the disease, different prob-
lems emerged. Problems with behav-
ior, cognition, and motivation were
reported to be some of the main is-
sues throughout the disease stages.
As the motor disorders progress,
cognitive impairments may interfere
with the learning of new skills. How-
ever, some simple strategies can be
implemented by family members or
caregivers and by therapists to com-
pensate for this situation. Participant
8 commented on one patient:
We did try to involve him and use
cueing references. We tried to keep
Figure 2.
Conceptual framework for physical therapy intervention in Huntington disease. Mod-
ified and reprinted with permission of Lippincott Williams & Wilkins from: Dal Bello-
Haas VD. A framework for rehabilitation of neurodegenerative diseases: planning care
and maximizing quality of life. Neurol Rep. 2002;26:115–129.
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instructions quite simple and straight.
We gave him pictures of exercises to
do, and we did not change the pro-
gram. We kept on repeating it in the
hope that he would learn that and
involved his wife quite heavily with
that as well to try to reinforce the
pattern of what we’re trying to get
him to learn.
Motivation also was considered to
have an impact on the physical ther-
apy program, with an individual’s
feelings of helplessness, depression,
and lack of understanding of the
need for physical therapy being the
main reasons identified for nonad-
herence. Some strategies for encour-
aging an individual’s participation in
a rehabilitation program and con-
tinuing home exercises were men-
tioned by participant 5, who said:
Family members have a big role really,
and it is largely that. If a patient goes
home, they won’t do the exercises
unless somebody is there trying to
motivate and encourage them to do
them. We get family and carers on
board and use diaries that they tick
when they have done exercises. That
helps. . . .
The uncontrolled behavior of people
with HD was also considered to have
a potential impact on the physical
therapy treatment. Participant 2, who
had extensive experience working
with people with HD and psychiatric
problems, suggested strategies to man-
age uncontrolled behavior. Participant
2 said:
We have patients with behavioral
problems that can have a massive im-
pact on physiotherapy. Clearly, we
have quite a lot of experience with
dealing with very difficult, aggressive
patients, so I normally manage that. I
try strategies to find ways around and
get them involved and doing some-
thing. If they are physically aggres-
sive, then I will just try to gently hold
the patient and try to facilitate them
through and just do a lot of positive
praise. . . . If they continue to be very
aggressive and resistant, then I try an-
other day.
The noticeable shift in the manage-
ment strategy from preventive in the
early stages to supportive in the late
stages was mentioned by participant
2, who said:
In terms of physiotherapy, I think
they should be more involved before
they become symptomatic to work
on things like core stability and the
other things that they could benefit
from in the long term. Right the way
through, it is spending more time on
thinking down the line, maintaining
their posture, prevent muscle short-
ening and when to keep them stand-
ing and weight bearing, making sure
posture is good at the meal time to
prevent aspiration and then to make
sure they are weight bearing evenly
when they are sitting down or lying to
prevent any pressure sores or these
sorts of things.
It is clear from the results presented
that each of the participants felt
strongly that, at the different stages
of HD, therapists needed different
management strategies, assessments,
and goals. Although preventive strat-
egies should be implemented in the
early stages of the disease, with the
aim of delaying a further deteriora-
tion in an individual’s condition, cur-
rent management is mostly support-
ive in the late stages of the condition.
Late-stage management aims to re-
duce the impact of complications.
Discussion
Physical therapy may play a role in
facilitating independence in activi-
ties of daily living for people with
HD. However, evidence for the effi-
cacy of physical therapy treatment in
people with HD is almost nonexist-
ent, with little systematic research
aimed at developing strategies for
managing the mobility deficits
present in this condition. Currently,
for physical therapists working with
people with HD, there is little docu-
mented information to guide their
intervention strategies. The results of
the present study have provided a
framework that may help to better
direct physical therapists in the pro-
vision of services for people with HD
and to facilitate the development of
efficacy studies for people with HD.
Three subthemes and one master
theme emerged from the interviews.
The first subtheme involved physi-
cal therapy assessment procedures
for people with HD. The UHDRS
was not reported as being used, al-
though it has a high degree of valid-
ity and reliability for motor scores,
meaning that it can be used for track-
ing HD clinical features over time.20
Functional assessments were con-
sidered the most appropriate meth-
ods of evaluation. Measures such as
the Berg Balance Scale and the TUG,
which are used for people with other
conditions, were recommended for
people with HD. There is a need to
develop appropriate outcome mea-
sures that are sensitive to physical
therapy-related changes and that con-
sider both impairments and associ-
ated functional limitations for people
with HD.
The impact of cognition may be a
limitation with any of the suggested
outcome measures. Although the
TUG has been recommended as a
screening tool for identifying older
people who are at risk for falling,21
poor performance on the TUG may
be attributed to cognitive impair-
ments. For this particular test (as
for most functional tests that are
timed), an understanding of the in-
structions and interactions among
the patient, the assessor, and the en-
vironmental setting are required.22
Given the deterioration of cerebral
integration and processing of sen-
sory (visual, vestibular, and proprio-
ceptive) information in the presence
of cognitive impairments,23 mobility
functions such as walking can be
negatively influenced. It has been
found that slower gait speed, de-
ceased step length, and increased
step-to-step variability are more com-
mon in people with cognitive impair-
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ments than in older adults who are
healthy.24,25
For the second subtheme, the
present study demonstrated the un-
derutilization of physical therapy ser-
vices in managing HD, particularly in
the early stages of the condition. Re-
ferrals for physical therapy services
seem to be occurring in the middle
and late stages, with insufficient re-
ferrals occurring in the presymptom-
atic and early stages.
Despite the underutilization of phys-
ical therapy services in the early
stages of the disease, the present
study highlighted the benefits of in-
tervention soon after diagnosis. A
physical therapy program imple-
mented in the early stages and di-
rected toward improving impair-
ments such as reduced flexibility,
coordination, balance, and muscle
strength (force-generating capacity)
has the potential to reduce disease
manifestations and improve an indi-
vidual’s quality of life.2 The impor-
tance of providing physical therapy
in the early stages of the disease has
a solid scientific foundation and the-
oretical support in recent mouse
model studies.8,9,26,27 These studies
suggested that environmental stimu-
lation in the early stages delayed the
degenerative loss of cerebral volume
in mice. This remarkable effect of
environmental enrichment in delay-
ing the onset of the disease in af-
fected mice inferred a positive im-
pact of physical therapy programs in
humans.
In the third subtheme, falls were
considered a major issue, particu-
larly toward the late stages of the
disease. Although the incidence of
falls in HD has not been empirically
determined, there is some evidence
that falls do occur in people with
HD. In a gait study of people with
HD, it was reported that 11 of 13
people had a history of 2 or more
falls.28 This finding is in agreement
with data from our questionnaires, in
that 95.3% of the respondents con-
sidered their patients with HD to be
at risk for falling, with balance and
loss of coordination as the main con-
tributing factors. Interestingly, falls
prevention programs did not seem to
be routinely used by therapists re-
sponding to the questionnaire. Al-
though falls are considered to be one
of the major physical therapy-related
issues associated with HD,1,7,29–31
the reasons for falls occurring in peo-
ple with HD are unclear. Falling in
HD is a multifactorial issue, with im-
paired postural stability, dystonic
postures, and gait disturbances con-
sidered contributing factors.32 Falls
and a loss of independent ambula-
tion33 are often factors that precipi-
tate admission to nursing homes.
The master theme that evolved from
the analysis of the interviews was
overriding and connected the 3 sub-
themes: Physical therapy manage-
ment in people with HD, both eval-
uation and intervention, must be
adaptable to the individual and to the
stage of the disease. This theme has
implications for future physical ther-
apy trials for HD, stratifying people
according to the stages of the con-
dition and then evaluating the ef-
fectiveness of various management
approaches at these stages. Clear
definitions of specific interventions
and consensus as to best practice
in physical therapy are essential to
providing the required evidence to
justify physical therapy interven-
tions34,35 and are even more essential
in complex, changing conditions
such as HD. Furthermore, a clear un-
derstanding of the cognitive, motiva-
tional, and behavioral issues that may
affect treatment at different stages of
the disease is required. Developing
appropriate physical therapy inter-
vention programs for HD is likely to
be complex,5 but a clear understand-
ing of the components of the inter-
ventions, factors that influence re-
sponses to treatment, and potential
mechanisms that may influence out-
comes is essential before the initia-
tion of large-scale trials.36
Conclusion
The results of this study lend support
to the suggestion that physical ther-
apist management should be modi-
fied according to the different stages
of the condition. The study was lim-
ited in that it was conducted only in
the United Kingdom with a relatively
small purposive sample. Despite the
limitations, there are implications for
future physical therapy trials for HD,
stratifying people according to the
stages of the condition and then eval-
uating the effectiveness of various
management approaches at these
stages. Rather than relying on clinical
judgment for treatment options, ther-
apists may use the information gath-
ered in this study to help them make
better decisions based on consensus
recommendations from people work-
ing in the field and justified by the
currently available evidence. The in-
formation gathered in this study also
may facilitate the development of stan-
dards of care and the design of future
physical therapy trials.
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Appendix.
Interview Schedule
Greeting:
Thank you for agreeing to this interview. We want to explore your experiences of assessment and treating people with
Huntington disease, which we will refer to as HD. The interview will last approximately 30 to 45 minutes, and it will be audio
recorded using a dictaphone. Written notes will be taken during the interview by an additional researcher. After the interview,
the recording will be transcribed. The transcript will be sent to you to see if it represents your ideas.
We have sent you an information sheet and consent form. Have you read the documentation, and do you agree to participate and
consent to the audio recording?
Are you happy to continue?
Introductory Questions:
1. Can you describe your physical therapy training?
FOLLOW-UP:
—How long ago did you qualify as a physical therapist?
—What was your qualification?
—From where did you get your qualification?
2. Can you tell me about your past and current work experience?
FOLLOW-UP:
—Experience in HD, including any postgraduate training.
3. How many patients with HD do you treat per year?
4. Referring to the stages of HD as pre (presymptomatic), early (mild impairment), mid (mild to moderate impairment), and late
(severe impairment, dependent for all care), at what stage of the condition usually are the patients that you treat?
5. How are they usually referred into your service?
FOLLOW-UP:
—What is the most frequent source of referral?
—What are the most frequent reasons for referral?
Main Questions:
1. According to the stage of the condition, what are the main problems that patients with HD have?
2. How do you usually assess these problems?
FOLLOW-UP:
—What outcome measures do you routinely use when treating patients with HD?
3. About your treatment plan. What treatments would you normally provide when dealing with patients with HD?
FOLLOW-UP:
—How could this differ according to the stage of the condition?
—When is the best time to address the problems?
—What is the average frequency of treatment according to the stage of the condition?
—What is your strategy to reduce the risk of falls?
—What is your provision for the use of walking aids and assistive devices?
—What support or advice is given to the family as a part of the treatment plan?
4. Do you consider behavioral problems with HD to affect your treatment?
FOLLOW-UP:
—Could you explain how and why?
5. Do you consider dementia in patients with HD to affect your treatment?
FOLLOW-UP:
—Could you explain how and why?
6. What affects or limits your proposed treatment?
7. Does your department have a care pathway for dealing with HD?
FOLLOW-UP:
—If yes, could you please explain it?
—If no, what is your opinion about using a standardized care pathway set up for dealing with HD?
—What are the most important components?
—How would it be structured?
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